RXEI.US RxElite Inc

Healthcare Pharmaceuticals USA Stocks
- USD
Market cap
-
P/E
-
P/B
0.01x
ROE
-231.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2008.

Is RXEI.US undervalued?

Graham number

The Graham number of RxElite Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RxElite Inc fundamental analysis

No fundamental analysis for RxElite Inc yet.

RxElite Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RxElite Inc

RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs. The company, through its subsidiaries, also manufactures active pharmaceutical ingredients for pharmaceutical companies in the United Sta…

Full company profile